- Condition: Neuroblastoma
Interventions: Drug: MLN8237; Drug: Irinotecan; Drug: Temozolomide
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Active, not recruiting - verified May 2012 - Condition: Injury Prevention
Intervention: Behavioral: Passenger effect
Sponsors: Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke
Recruiting - verified May 2012 - Condition: Seniors With Mobility Limitations
Interventions: Other: Mobility self-management with Mentor; Other: Mobility self-management with guidebook
Sponsors: McGill University; McGill University; Richard and Edith Strauss Foundation of Canada
Not yet recruiting - verified May 2012 - Conditions: Alcohol Abuse; Drug Abuse; Mood Disorder; Anxiety Disorder; Conduct Disorder
Interventions: Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions; Behavioral: Personality-targeted interventions
Sponsors: Université de Montréal; Université de Montréal
Recruiting - verified May 2012 - Condition: Neuroblastoma
Intervention:
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium
Recruiting - verified April 2012 - Condition: Bipolar Depression
Interventions: Device: Magstim Rapid2 Stimulator; Device: Magstim Rapid2 Stimulator
Sponsors: Douglas Mental Health University Institute; Douglas Mental Health University Institute
Not yet recruiting - verified April 2012 - Condition: Coronary Artery Disease
Interventions: Procedure: LIMA to SVG Bridge Technique; Procedure: Conventional CABG
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified April 2012 - Condition: Shoulder Dislocation
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: Bipolar Disorder
Interventions: Drug: Bupropion; Device: Repetitive Transcranial Magnetic Stimulation; Other: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified April 2012 - Condition: Vestibulodynia
Intervention: Behavioral: Cognitive-behavioral couple therapy (CBCT)
Sponsors: Université de Montréal; Université de Montréal
Not yet recruiting - verified May 2012 - Conditions: Postpartum Hemorrhage; Uterine Atony
Intervention: Drug: Carbetocin
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital; Université de Montréal
Recruiting - verified April 2012 - Conditions: Mourning,; Grief,; Bereavement.
Intervention: Behavioral: Group intervention based on mutual aid.
Sponsors: Université de Montréal; Université de Montréal
Not yet recruiting - verified May 2012 - Condition: Parkinson's Disease
Interventions: Other: Argentinean Tango classes; Other: Simple pamphlet about the exercise in PD
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified April 2012 - Condition: Pain
Intervention: Other: Telephone follow-up
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Completed - verified March 2012 - Conditions: Smoking; Excessive Drinking; Lack of Physical Activity; Malnutrition; Obesity
Intervention: Other: WHO-HPH Recognition Process
Sponsors: Bispebjerg Hospital; Bispebjerg Hospital; World Health Organization Regional Office for Europe; International Network of Health Promoting Hospitals & Health Services (HPH); National HPH Network of Austria; National HPH Network of the Czech Republic; National HPH Network of Slovenia; National HPH Network of Switzerland; Regional HPH Network of Taiwan; National HPH Network of the Republic of Korea; Regional HPH Network of Victoria, Australia; Regional HPH Network of Montreal, Canada; National HPH Network of Italy
Recruiting - verified March 2012 - Condition: Hypotension
Interventions: Drug: 2 ml bupivacaine; Drug: 1.5 ml bupivicaine.
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: exercise
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Cardiac Surgery
Intervention: Drug: Regular human insulin injection
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified May 2012 - Condition: Colorectal Cancer
Interventions: Other: Oncology Interactive Navigator; Other: Routine Care
Sponsors: McGill University; McGill University
Recruiting - verified May 2012 - Condition: Chronic Hand Dermatitis
Intervention: Drug: Acitretin
Sponsors: Innovaderm Research Inc.; Innovaderm Research Inc.; Tribute Pharmaceuticals
Not yet recruiting - verified March 2012 - Condition: Pain
Interventions: Drug: 88% sucrose po; Drug: placebo po
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Recruiting - verified February 2012 - Condition: Pain
Interventions: Drug: 88% sucrose po solution; Drug: placebo po
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Not yet recruiting - verified February 2012 - Conditions: Diabetes; Stroke; Obesity
Intervention:
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified March 2012 - Condition: Healthy
Intervention: Dietary Supplement: omega-3 fatty acids
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Condition: Healthy
Intervention: Dietary Supplement: omega-3 fatty acid
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Completed - verified April 2012 - Conditions: Pulmonary Disease; Pulmonary Hypertension
Intervention: Radiation: 99mTC-PulmoBind
Sponsors: Montreal Heart Institute; Montreal Heart Institute
Recruiting - verified February 2012 - Condition: Metastasis to Brain of Primary Cancer
Intervention: Radiation: Whole brain external beam radiation with simultaneous in-field boost
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Ontario Institute for Cancer Research
Recruiting - verified February 2012 - Conditions: Colorectal Neoplasm; Biliary Tract Neoplasm; Liver Neoplasm
Interventions: Dietary Supplement: Whey protein and dietary supplements; Other: prehab exercise
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified February 2012 - Condition: Other Eating Disorders
Intervention: Behavioral: Conscious food tasting intervention
Sponsors: Laval University; Laval University; Canadian Foundation for Dietetic Research (CFDR)
Active, not recruiting - verified March 2012 - Condition: Surgical Site Infection After Major Surgery
Interventions: Other: Hyperinsulinemic normoglycemic clamp; Other: Standard glucose management
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified February 2012 - Condition: Obesity
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Condition: Pulmonary Arterial Hypertension
Intervention: Other: Submaximal exercises
Sponsors: Laval University; Laval University
Recruiting - verified January 2012 - Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Saline; Drug: Dexamethasone; Drug: Dexamethasone
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified May 2012 - Condition: Type-1 Diabetes
Intervention: Device: Dual Hormone closed-loop system
Sponsors: Institut de Recherches Cliniques de Montreal; Institut de Recherches Cliniques de Montreal; McGill University Center for Intelligent Machines; Montreal Children's Hospital
Recruiting - verified January 2012 - Conditions: Depression; Chronic Disease
Interventions: Behavioral: Supported self-care; Behavioral: Unsupported self-care
Sponsors: McGill University; McGill University; Fonds de la Recherche en Santé du Québec
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fentanyl; Drug: Placebo comparator
Sponsors: Laval University; Laval University
Completed - verified January 2012 - Condition: Low Back Pain
Interventions: Drug: Bupivacaine; Drug: Saline
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified January 2012 - Condition: Radiculopathy
Interventions: Procedure: Program targeting the opening of intervertebral foramen; Procedure: Conventional Rehabilitation Program
Sponsors: Laval University; Laval University; Fonds de la Recherche en Santé du Québec
Not yet recruiting - verified December 2011 - Condition: Solid Neoplasms
Intervention: Device: Endosonography guided fine needle aspiration cytology ( Cook Medical, Boston Scientific)
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified December 2011 - Condition: Acute Respiratory Distress Syndrome (ARDS)
Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator; Procedure: Lung Protective Ventilation
Sponsors: Canadian Critical Care Trials Group; Canadian Critical Care Trials Group; Canadian Institutes of Health Research (CIHR); McMaster University; University of Toronto
Recruiting - verified January 2010 - Condition: Benign Prostate Hyperplasia
Interventions: Procedure: HOLEP (Holmium Laser Enucleation of The Prostate); Procedure: PVP-XPS (Photoselective Vaporization of the Prostate)
Sponsors: Royal Victoria Hospital, Canada; Royal Victoria Hospital, Canada; McGill University
Recruiting - verified January 2012 - Conditions: Cough; Anesthesia
Interventions: Drug: Remifentanil; Drug: Remifentanil
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified April 2012 - Condition: Coronary Artery Disease
Intervention: Other: Patent hemostasis and heparin
Sponsors: Laval University; Olivier F. Bertrand; Community Medical Center, Scranton, PA; Sheth Vadilal Sarabhai General Hospital
Completed - verified December 2011 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D; Drug: Placebo
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; Canadian Institutes of Health Research (CIHR); Laval University
Not yet recruiting - verified December 2011 - Conditions: Hypotension; Low Blood Pressure; Prematurity of Fetus
Interventions: Drug: Dopamine hydrochloride; Drug: Dextrose 5%
Sponsors: University College Cork; University College Cork; BrePco Biopharma Limited; Cork University Hospital; Katholieke Universiteit Leuven; Univerzita Karlova v Praze; Centre hospitalier universitaire Sainte-Justine; University College Dublin; Coombe Women and Infants University Hospital; University of Alberta; Royal College of Surgeons, Ireland; GABO:milliarium mbH & Co. KG; National de la Santé et de la Recherche Medicale; University College, London; Clininfo S.A.
Not yet recruiting - verified November 2011 - Conditions: Female Infertility; Polycystic Ovary Syndrome; Obesity
Intervention: Behavioral: Interdisciplinary lifestyle intervention
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified November 2011 - Conditions: Type 2 Diabetes; Hypertension
Interventions: Behavioral: Step count prescription; Behavioral: Usual care
Sponsors: McGill University Health Center; McGill University Health Center; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Conditions: Colon Cancer; Inflammatory Bowel Diseases; Diverticulitis
Interventions: Drug: Spinal analgesia; Drug: Patient Control Analgesia (PCA) Morphine
Sponsors: McGill University Health Center; McGill University Health Center
Completed - verified November 2011 - Conditions: Infection; Bone Neoplasms
Intervention: Procedure: Prophylactic Cefazolin Antibiotic Regimen
Sponsors: McMaster University; Michelle Ghert
Not yet recruiting - verified April 2012 - Conditions: Post-lumbar Puncture Headache; Backache
Interventions: Device: whitacre 24 gauge; Device: whitacre 22 gauge
Sponsors: McGill University; McGill University; funding: McGill Emergency Medicine 2010 Grant Competition
Recruiting - verified November 2011 - Condition: Cardiac Sarcoidosis
Intervention:
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Ontario Ministry of Health and Long Term Care
Not yet recruiting - verified December 2011 - Condition: Esophageal Cancer
Intervention:
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified November 2011 - Condition: Acute Myeloid Leukemia
Intervention:
Sponsors: Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke
Recruiting - verified May 2012 - Condition: Cancer of the Endometrium
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified November 2011 - Condition: Carotid Plaque
Intervention: Other: Imaging
Sponsors: University of Western Ontario, Canada; University of Western Ontario, Canada; Canadian Institutes of Health Research (CIHR)
Recruiting - verified October 2011 - Condition: Vestibulodynia
Interventions: Procedure: Multimodal physiotherapy; Drug: lidocaine
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Santé du Québec
Recruiting - verified October 2011 - Conditions: Cough; Anesthesia
Interventions: Drug: Remifentanil; Drug: Alkalinized lidocaine
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Interventions: Device: Transcranial Direct Current Stimulation; Device: Transcranial Direct Current Stimulation
Sponsors: Douglas Mental Health University Institute; Douglas Mental Health University Institute
Not yet recruiting - verified April 2012 - Condition: Obesity
Intervention: Behavioral: Supervised physical activity
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified October 2011 - Condition: Head Trauma
Interventions: Other: 4-views series; Other: 2-views serie
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Recruiting - verified October 2011 - Conditions: Breast Cancer; Head and Neck Cancer
Interventions: Other: Aveeno cream and Flamazine cream; Other: Neoviderm cream; Other: Aveeno cream and Flamazine cream; Other: Neoviderm cream
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Sir Mortimer B. Davis - Jewish General Hospital; Avario Healthcare Inc.
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Radiation: hypofractionation; Radiation: conventional
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Sir Mortimer B. Davis - Jewish General Hospital
Not yet recruiting - verified September 2011 - Condition: Mild Cognitive Impairment
Interventions: Other: Cognitive intervention; Other: Psychosocial intervention
Sponsors: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Laval University
Not yet recruiting - verified October 2011 - Conditions: Visceral Obesity; Atherosclerosis; Metabolic Syndrome
Intervention:
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified May 2012 - Condition: Solar Skin Damage
Interventions: Other: Flavanol-rich chocolate; Other: Flavanol-free chocolate
Sponsors: Laval University; Laval University
Active, not recruiting - verified May 2012 - Condition: Surgery
Intervention:
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified September 2011 - Condition: Lung Cancer
Intervention: Procedure: Cervical mediastinoscopy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified September 2011 - Condition: Bronchopulmonary Dysplasia
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified September 2011 - Condition: Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Vitamin D; Dietary Supplement: placebo
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified April 2012 - Conditions: Healthy; High Velocity Fracture; Cranial Trauma; Spinal Trauma
Intervention:
Sponsors: Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Lidocaine; Drug: Placebo
Sponsors: Jewish General Hospital; Jewish General Hospital
Terminated - verified April 2012 - Conditions: Respiratory Tract Infections; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Lung Diseases, Interstitial
Interventions: Drug: Prednisone; Drug: Azithromycin; Drug: Montelukast; Drug: Symbicort
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital; The Canadian Blood and Marrow Transplant Group
Recruiting - verified January 2012 - Condition: Dementia
Intervention:
Sponsors: Laval University; Laval University
Not yet recruiting - verified September 2011 - Condition: Cerebral Hypoxia
Intervention: Procedure: strategies to reverse decrease in rSO2
Sponsors: Montreal Heart Institute; Montreal Heart Institute; Université de Montréal
Recruiting - verified September 2011 - Condition: Valvular Cardiac Surgery
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified August 2011 - Condition: Learning Disabilities
Interventions: Other: Group tutoring program; Other: Control groups with no intervention; Other: Theatre workshops
Sponsors: McGill University Health Center; McGill University Health Center
Active, not recruiting - verified March 2012 - Condition: Suspected Biliary Obstruction
Interventions: Procedure: ERCP; Procedure: MRCP
Sponsors: McGill University Health Center; McGill University Health Center; Alberta Heritage Foundation for Medical Research (AHFMR); American College of Gastroenterology; American Digestive Health Foundation; Canadian Institute for Health Research (CIHR)
Terminated - verified August 2011 - Conditions: Syncope; Heart Block; Conduction Disorder of the Heart
Interventions: Procedure: pacemaker; Procedure: implantable loop recorder
Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR); Vanderbilt University
Recruiting - verified April 2012 - Condition: Skin Burn Extensive
Intervention:
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified August 2011 - Condition: Gastrointestinal Bleeding
Interventions: Device: Capsule GIVEN IMAGING; Procedure: Push-Enteroscopy
Sponsors: McGill University Health Center; McGill University Health Center; American Society for Gastrointestinal Endoscopy; American College of Gastroenterology; Canadian Institutes of Health Research (CIHR)
Completed - verified August 2011 - Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: Catheter ablation-based AF rhythm control; Drug: Medication Rate Control
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Conditions: Diabetes Mellitus, Type 2; Hypertension; Dyslipidemias; Cholesterol, LDL; Comorbitdity
Interventions: Other: Facilitation; Other: Passive diffusion (usual implementation strategy)
Sponsors: Fonds de la Recherche en Santé du Québec; Fonds de la Recherche en Santé du Québec; Université de Montréal
Recruiting - verified August 2011 - Conditions: Obstetric Anesthesia; Spinal Anesthesia; Hypotension; Fluid Therapy; Cesarean Section
Intervention: Drug: Hydroxyethylstarch 130/0.4
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital; Université de Montréal
Recruiting - verified April 2012 - Conditions: Complications Due to Coronary Artery Bypass Graft; Graft Failure
Interventions: Procedure: On-pump CABG; Procedure: Off-pump CABG
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified August 2011 - Condition: Postoperative Protein Catabolism
Interventions: Other: Intravenous nutrition with glucose and amino acids; Other: Intravenous nutrition with amino acids
Sponsors: McGill University Health Center; McGill University Health Center
Completed - verified August 2011 - Conditions: Anus Neoplasms; Rectal Neoplasms; Urogenital Neoplasms
Interventions: Other: Aveeno cream; Other: Alkagin paste
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Dr. Te Vuong; Avario Healthcare
Recruiting - verified May 2012 - Condition: Physical Therapy
Intervention: Other: Physiotherapy
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified June 2011 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D (Cholecalciferol ); Drug: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified July 2011 - Conditions: Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Type 2 Diabetes
Intervention: Drug: Liraglutide-metformin vs insulin-metformin
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Diabete Quebec; Radiological Society of North America Research and Education Foundation; Canadian Heads of Academic Radiology-GE Healthcare Development Award
Recruiting - verified July 2011 - Conditions: Parkinson's Disease; Insomnia
Interventions: Device: Light box (Litebook company); Behavioral: CBT and sleep hygiene; Drug: Doxepin and Zopiclone; Device: Light box ( Litebook company)
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified December 2011 - Condition: Second or Third Degree Burns
Intervention: Drug: 5% human albumin solution (HAS)
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Not yet recruiting - verified September 2011 - Condition: Advanced Rare Tumours
Interventions: Drug: Sunitinib; Drug: Temsirolimus
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: COPD Exacerbation
Interventions: Device: Automated settings on the oxygen delivery device; Device: Manual settings with FreeO2 system in collection mode
Sponsors: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Recruiting - verified May 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Device: Telehomecare (Intelligent Distance Patient Monitoring); Other: Standard education and follow up at diabetes clinic
Sponsors: Huot, Celine, M.D.; Huot, Celine, M.D.
Completed - verified July 2011 - Condition: Labour Dystocia
Intervention: Drug: Oxytocin
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; The Physicians' Services Incorporated Foundation; The Ottawa Hospital; Canadian Institutes of Health Research (CIHR); Sainte Justine Hospital Research Institute
Recruiting - verified March 2012 - Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil; Drug: Sugar Pill
Sponsors: Laval University; Laval University
Recruiting - verified January 2012 - Condition: Anxiety
Intervention: Behavioral: Dominique's Handy Tricks
Sponsors: Universite du Quebec en Outaouais; Universite du Quebec en Outaouais
Completed - verified July 2011 - Conditions: Cholelithiasis; Cholecystectomy
Interventions: Procedure: Laparoscopic cholecystectomy; Procedure: Minilaparoscopic cholecystectomy
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified April 2012 - Condition: Acute Myeloid Leukemia
Intervention:
Sponsors: Center for International Blood and Marrow Transplant Research; Center for International Blood and Marrow Transplant Research; Resource for Clinical Investigations in Blood and Marrow Transplantation (RCI-BMT); Pediatric Blood and Marrow Transplant Consortium
Recruiting - verified May 2012 - Condition: Obesity
Intervention: Other: Preceptorship and virtual community
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Completed - verified October 2011 - Conditions: Grief; Bereavement
Interventions: Behavioral: Meaning-Based Bereavement Group; Behavioral: Conventional Bereavement Group
Sponsors: Jewish General Hospital; Jewish General Hospital; McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Asthma
Interventions: Behavioral: Motivational Interviewing; Behavioral: Control
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; Jewish General Hospital
Recruiting - verified October 2011 - Condition: Lung Cancer
Interventions: Drug: Remifentanil; Drug: Dexmedetomidine
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital
Recruiting - verified June 2011 - Conditions: Social Anxiety; Schizophrenia
Interventions: Behavioral: Cognitive-Behavioral Therapy based intervention immediately; Behavioral: Wait list
Sponsors: McGill University; McGill University; Canadian Institute of Health Research Grant operating under Dr Martin Lepage
Recruiting - verified June 2011 - Condition: Influenza Vaccine
Interventions: Biological: Agriflu; Biological: Fluad; Biological: Intanza; Biological: Vaxigrip
Sponsors: University of British Columbia; University of British Columbia; PHAC/CIHR Influenza Research Network
Active, not recruiting - verified March 2012 - Conditions: Malignant Dysphagia; Esophageal Cancer
Interventions: Radiation: Brachytherapy; Procedure: Stent insertion
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified June 2011 - Condition: Intubation, Intratracheal
Interventions: Device: Miller laryngoscope; Device: Storz videolaryngoscope
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Recruiting - verified July 2011 - Condition: Achalasia
Intervention: Procedure: Endoscopic Peroral Myotomy
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified May 2012 - Condition: Stroke
Interventions: Biological: rfVIIa; Other: Standard saline solution
Sponsors: Sunnybrook Health Sciences Centre; Dr. David Gladstone; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Cancer
Intervention: Other: Self administered coping intervention
Sponsors: McGill University Health Center; McGill University Health Center; Louise Granofsky-Psychosocial Oncology Program, Segal Cancer Centre, Montreal
Suspended - verified May 2012 - Conditions: Colorectal Cancer; Colorectal Cancer Stage III
Interventions: Behavioral: multimodal prehabilitation; Behavioral: multimodal prehabilitation
Sponsors: McGill University Health Center; McGill University Health Center; Society of American Gastrointestinal and Endoscopic Surgeons
Recruiting - verified April 2012 - Conditions: Kidney Transplantation; Medication Adherence
Interventions: Device: Medminder adherence monitoring; Behavioral: Action-focused problem-solving; Device: Medminder dosage reminders
Sponsors: McGill University Health Center; McGill University Health Center; Children's Hospital of Philadelphia; Children's Hospital Medical Center, Cincinnati; Seattle Children's Hospital; University of Florida; Children's & Women's Health Centre of British Columbia; The Hospital for Sick Children
Recruiting - verified March 2012 - Conditions: Sepsis; Shock; Trauma
Intervention:
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation
Recruiting - verified August 2011 - Condition: Atherosclerosis
Intervention:
Sponsors: Canadian Atherosclerosis Imaging Network; Canadian Atherosclerosis Imaging Network; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Conditions: Disease Due to BK Polyomavirus; Kidney Transplant Infection
Intervention: Drug: Levofloxacin
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); St. Paul's Hospital, Canada; Vancouver General Hospital; University of Alberta; University of Manitoba; University Health Network, Toronto; St. Michael's Hospital, Toronto; St. Joseph's Healthcare Hamilton; London Health Sciences Centre; McGill University Health Center; Dalhousie University
Recruiting - verified March 2012 - Condition: Fibromyalgia
Interventions: Dietary Supplement: Omega-3 (oil); Dietary Supplement: Fatty Acids (placebo)
Sponsors: McGill University Health Center; McGill University Health Center; Alan Edwards Centre for Research on Pain
Recruiting - verified January 2012 - Condition: Urolithiasis
Intervention:
Sponsors: McGill University Health Center; McGill University Health Center
Active, not recruiting - verified April 2011 - Condition: Intracranial Aneurysm
Interventions: Procedure: flow diversion; Other: conservative management; Procedure: endovascular coiling; Procedure: balloon parent vessel occlusion; Procedure: surgical clipping
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified December 2011 - Condition: Preeclampsia
Interventions: Other: Flavanol-rich chocolate; Other: Placebo Chocolate
Sponsors: Laval University; Laval University
Recruiting - verified February 2012 - Condition: Intracranial Aneurysm
Interventions: Device: endovascular coiling with any type of currently approved coil (first or second generation); Device: endovascular stenting with or without coiling. The stent may be any of the currently approved stents for intracranial aneurysms.
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified December 2011 - Conditions: Iodine Deficiency; Goiter; Cretinism
Intervention: Other: Iodized salt
Sponsors: McGill University; McGill University; MicroNutrient Initiative; Ethiopian Health and Nutrition Research Institute (EHNRI)
Recruiting - verified February 2012 - Conditions: Carcinoma, Non-Small-Cell Lung; Cancer of the Gastrointestinal Tract
Interventions: Behavioral: Standard Exercise; Behavioral: Qigong Exercise
Sponsors: McGill University; McGill University; Jewish General Hospital
Active, not recruiting - verified February 2011 - Condition: Neoplasm of Mediastinal Lymph Nodes
Intervention:
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal; C.E.T.O.C. CHUM Endoscopic Tracheo-Bronchial and Oesophageal Center
Completed - verified November 2011 - Conditions: Pre-Eclampsia; Fetal Growth Retardation; Prematurity of Fetus; Placental Insufficiency
Interventions: Drug: Acetylsalicylic acid (ASA) 160; Drug: Acetylsalicylic acid (ASA) 80
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec
Recruiting - verified January 2012 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Pancreatitis, Chronic
Interventions: Drug: Bupivacaine & Triamcinolone Acetonide; Other: No intervention except EUS procedure
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Erasme University Hospital
Recruiting - verified December 2011 - Condition: Intubation Conditions
Intervention: Other: Intubation
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified June 2011 - Condition: Double Lumen Tube Intubation
Intervention:
Sponsors: Laval University; Laval University
Completed - verified February 2012 - Conditions: Pancreatic Cancer; Unresectable Pancreatic Cancer
Intervention: Radiation: stereotactic body radiotherapy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified December 2011 - Condition: Type 1 Diabetes
Interventions: Device: Conventional continuous subcutaneous insulin infusion therapy; Device: Dual-hormone closed-loop
Sponsors: Institut de Recherches Cliniques de Montreal; Institut de Recherches Cliniques de Montreal; McGill University; Montreal Children's Hospital; Diabète Québec; Medtronic Minimed
Completed - verified January 2012 - Condition: Lung Cancer
Intervention: Other: Multi-faceted intervention to improve continuity of care
Sponsors: Laval University; Laval University; Canadian Cancer Society
Recruiting - verified January 2012 - Conditions: Healthy; Obesity
Interventions: Behavioral: 2 servings of dairy/day and exercise counselling; Behavioral: 4 servings of dairy/day and exercise counselling
Sponsors: McGill University; McGill University; Dairy Farmers of Canada
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: McGill University Health Center; McGill University Health Center; McGill University
Recruiting - verified September 2011 - Conditions: Venous Thromboembolism; Postpartum
Interventions: Drug: Dalteparin Sodium; Drug: 0.9% Bacteriostatic Sodium Chloride
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Hepatitis C Virus
Intervention: Drug: Insulin
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified August 2011 - Conditions: Intubation; General Anesthesia
Interventions: Procedure: Tracheal intubation through LMA-Fastrach®; Procedure: Tracheal intubation through I-gel®
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified April 2012 - Conditions: Inter-examiner Reliability; Location and Nature of Restriction or Lesion; Non-specific Back Pain
Intervention: Other: General Osteopathic Evaluation
Sponsors: Kirnan, Jaime; Kirnan, Jaime
Completed - verified June 2011 - Conditions: Neurosurgery; Orthopedic Surgery; Red Blood Cell Transfusion
Interventions: Drug: Tranexamic Acid; Drug: Placebo
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified April 2012 - Condition: Any Disease in Children Who Receive a Stem Cell Transplantation With Busulfan IV
Intervention:
Sponsors: Swiss Pediatric Oncology Group; Swiss Pediatric Oncology Group; European Group for Blood and Marrow Transplantation
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Bisoprolol; Drug: Placebo
Sponsors: Laval University; Laval University
Completed - verified November 2010 - Condition: Laparoscopic Colectomy
Intervention: Procedure: laparoscopic colectomy
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified April 2012 - Condition: Bone Metastases
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified March 2012 - Conditions: Intestinal Disease; Feeding Disorder Neonatal
Intervention: Drug: Lactated Ringer's Solution
Sponsors: McGill University Health Center; McGill University Health Center
Active, not recruiting - verified August 2011 - Condition: Hyperaldosteronism
Intervention:
Sponsors: University Hospital Padova; University Hospital Padova
Completed - verified December 2011 - Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: rasagiline
Sponsors: University of Kansas; Yunxia Wang, MD; Western ALS Study Group
Active, not recruiting - verified March 2012 - Condition: Renal Calculi (Kidney Stones)
Intervention: Procedure: ESWL: Extraporeal Shock Wave Lithotripsy Intervention
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Colon Cancer
Interventions: Dietary Supplement: Oral Nutrition with dextrose and pressurized whey protein; Dietary Supplement: Peripheral Parenteral Nutrition
Sponsors: McGill University Health Center; McGill University Health Center; Montreal General Hospital; McGill University
Completed - verified February 2012 - Condition: Breast Cancer
Intervention: Other: art therapy
Sponsors: McGill University Health Center; McGill University Health Center; The Cedars Cancer Institute
Recruiting - verified August 2011 - Condition: Gestational Diabetes Mellitus
Interventions: Drug: Insulin; Drug: Metformin, glyburide and insulin
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified November 2011 - Condition: Cardiac Disease
Interventions: Drug: Atenolol; Drug: Telmisartan; Drug: Atenolol Placebo; Drug: Telmisartan Placebo
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; Population Health Research Institute
Recruiting - verified March 2012 - Condition: Non Small Cell Lung Cancer
Intervention: Procedure: Transthoracic Ultrasound
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified November 2011 - Condition: Lung Cancer
Intervention: Procedure: intracavitary ultrasound
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified November 2011 - Conditions: Pain, Postoperative; Breast Cancer; Postoperative Nausea and Vomiting
Interventions: Drug: fentanyl; Drug: beta-blocker (esmolol, metropolol)
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Condition: Parkinson's Disease
Intervention: Drug: Caffeine alkaloid
Sponsors: McGill University Health Center; McGill University Health Center; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Healthy
Intervention: Dietary Supplement: Cholecalciferol (D3) or ergocalciferol (D2)
Sponsors: McGill University; McGill University; Canadian Foundation for Dietetic Research (CFDR)
Completed - verified March 2012 - Conditions: Leukemia; Solid Tumours
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Conditions: Medication Reconciliation; Adverse Drug Events
Intervention: Other: Electronic Medication Reconciliation
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Systemic Lupus Erythematosus
Intervention: Other: Standard care plus Yoga
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified July 2011 - Condition: Atrial Fibrillation
Interventions: Drug: OMEGA-3; Drug: Placebo soybean oil
Sponsors: Montreal Heart Institute; Montreal Heart Institute
Recruiting - verified July 2011 - Condition: Pulmonary Embolism
Intervention:
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Sir Mortimer B. Davis - Jewish General Hospital
Recruiting - verified July 2010 - Conditions: Anesthesia, General; Laparoscopic Surgery
Intervention: Drug: Pregabalin
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified December 2011 - Conditions: Colon Cancer; Inflammatory Bowel Diseases; Diverticulitis
Interventions: Drug: Lidocaine; Procedure: Thoracic epidural block
Sponsors: McGill University Health Center; McGill University Health Center
Completed - verified November 2011 - Conditions: Opioid Consumption; Incidence of Nausea and Vomiting; Postoperative Pain; Assessment of Recovery
Interventions: Procedure: Normal saline via TAP catheters; Procedure: Lidocaine via TAP catheters
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified February 2012 - Condition: Melanoma
Interventions: Drug: rIL-21; Drug: Dacarbazine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; ST Elevation Myocardial Infarction; Percutaneous Coronary Intervention
Intervention: Procedure: Percutaneous Coronary Intervention with or without manual aspiration thrombectomy
Sponsors: Population Health Research Institute; Population Health Research Institute
Recruiting - verified March 2012 - Conditions: Polypharmacy; Incontinence; Insomnia; Anxiety
Intervention: Behavioral: knowledge transfer tool
Sponsors: Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: The Role of Multimedia on Retention and Comprehension of Key Concepts for Surgical Options in Newly Diagnosed Breast Cancer Patients.
Interventions: Other: This group of patients will be exposed to multimedia; Other: No Media
Sponsors: McGill University Health Center; McGill University Health Center
Enrolling by invitation - verified April 2012 - Conditions: Eating; Obesity
Interventions: Behavioral: Healthy; Behavioral: Diet; Behavioral: Unhealthy
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Santé du Québec; Danone Institute International
Completed - verified February 2012 - Condition: Lung Cancer
Interventions: Procedure: thoracic ultrasound; Procedure: pleural aspiration
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Fonds de la Recherche en Santé du Québec; Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Society of University Surgeons
Completed - verified June 2011 - Condition: Breast Cancer
Interventions: Drug: Foretinib; Drug: Lapatinib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified April 2012 - Condition: Recurrent Breast Cancer
Intervention: Drug: Foretinib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Behavioral: Motivational interviewing; Behavioral: Usual care
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal
Active, not recruiting - verified June 2011 - Condition: Drug Interaction Potentiation
Intervention: Drug: Rosuvastatin, Pantoprazole
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Completed - verified December 2011 - Condition: Humeral Diaphysis Fracture
Interventions: Procedure: Plate and screws or nailing; Device: Hanging Support System (HSS) brace
Sponsors: Hopital de l'Enfant-Jesus; Hopital de l'Enfant-Jesus
Recruiting - verified November 2011 - Conditions: Obesity; Obstructive Sleep Apnea
Intervention:
Sponsors: Katz, Sherri Lynne, M.D.; Katz, Sherri Lynne, M.D.; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: Fracture of Proximal Humerus
Interventions: Device: PHILOS™ locked plate system by Synthes Canada©; Other: Early and intensive exercise program; Other: Standard rehabilitation program
Sponsors: Hopital de l'Enfant-Jesus; Hopital de l'Enfant-Jesus
Recruiting - verified November 2011 - Condition: Glenohumeral Joint Dislocation
Interventions: Device: Donjoy ER brace; Device: Thoraco brachial brace
Sponsors: Hopital de l'Enfant-Jesus; Hopital de l'Enfant-Jesus
Recruiting - verified November 2011 - Condition: Acromio-clavicular Joint Dislocation (Type III)
Interventions: Other: Conservative treatment - brace; Device: Hook plate by Synthes
Sponsors: Hopital de l'Enfant-Jesus; Hopital de l'Enfant-Jesus
Recruiting - verified November 2011 - Condition: Obesity
Interventions: Other: Probiotic; Other: Placebo
Sponsors: Laval University; Laval University; Nestle Research Center
Recruiting - verified September 2011 - Condition: Metastatic Sarcoma
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Condition: Chronic Hepatitis C - Genotype 3
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified February 2010 - Conditions: Acute Coronary Syndrome; Major Depressive Episode
Intervention: Drug: Citalopram
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Montreal Heart Institute
Terminated - verified June 2011 - Condition: Pregnancy
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified March 2012 - Condition: Thrombosis
Interventions: Drug: Variation of heparin dose; Drug: Variation of heparin dose
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified April 2012 - Condition: Acute Myeloid Leukemia
Interventions: Drug: Ribavirin; Drug: Cytarabine arabinoside
Sponsors: Jewish General Hospital; Jewish General Hospital; The Leukemia and Lymphoma Society
Recruiting - verified March 2010 - Condition: Neuralgic Facial Pain
Interventions: Dietary Supplement: Isolated soy protein; Dietary Supplement: Isolated milk protein
Sponsors: McGill University Health Center; McGill University Health Center; Louise & Alan Edwards Foundation; Alan Edwards Centre for Research on Pain
Recruiting - verified January 2012 - Conditions: Postmenopause; Overweight
Interventions: Behavioral: Placebo + exercise; Dietary Supplement: Phytoestrogens without exercise; Other: Phytoestrogens + exercise; Other: Placebo without exercise
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR); Centre de recherche sur le vieillissement du CSSS-IUGS
Recruiting - verified June 2010 - Condition: Cancer
Intervention: Dietary Supplement: vitamin C (ascorbic acid)
Sponsors: Jewish General Hospital; Jewish General Hospital
Recruiting - verified January 2010 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Conditions: Oral Cancer; High-grade Precancer
Interventions: Procedure: Fluorescence visualization device; Procedure: Fluorescence visualization device
Sponsors: University of British Columbia; University of British Columbia; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting - verified December 2011 - Condition: Esophageal Cancer
Interventions: Procedure: Endoscopic Ultrasound (EUS); Procedure: Endobronchial Ultrasound (EBUS)
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); C.E.T.O.C. - CHUM Endoscopic Tracheobronchial and Oesophageal Center; Marcel and Rolande Gosselin Chair in Thoracic Surgical Oncology; Fonds de la Recherche en Santé du Québec; Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Completed - verified November 2011 - Conditions: Myocardial Infarct; Heart Failure
Intervention: Procedure: Injection of stem cells at time of coronary artery bypass grafting
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Miltenyi Biotech inc.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Maisonneuve-Rosemont Hospital
Recruiting - verified December 2011 - Condition: Cardiovascular Disease
Intervention:
Sponsors: Montreal Heart Institute; Montreal Heart Institute; Fonds de la Recherche en Santé du Québec
Active, not recruiting - verified July 2011 - Condition: Diabetes Mellitus
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Active, not recruiting - verified November 2011 - Condition: Gestational Diabetes Mellitus
Intervention: Procedure: 50 g oral glucose challenge test - 75 g oral glucose tolerance test
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Diabetes Association
Recruiting - verified November 2011 - Condition: Conscious Sedation
Intervention: Drug: controlled administration of propofol
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified November 2009 - Condition: Lung Cancer
Interventions: Procedure: Cervical Mediastinoscopy; Procedure: Endobronchial Ultrasound (EBUS); Procedure: Endoscopic Ultrasound (EUS)
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Fonds de la Recherche en Santé du Québec; Society of University Surgeons; Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: Paclitaxel; Drug: Trastuzumab; Drug: Neratinib; Drug: Trastuzumab (post surgery); Drug: Doxorubicin; Drug: Cyclophosphamide
Sponsors: National Surgical Adjuvant Breast and Bowel Project (NSABP); National Surgical Adjuvant Breast and Bowel Project (NSABP); Wyeth Pharmaceuticals, Inc., a Pfizer Company
Recruiting - verified February 2012 - Condition: Preterm Birth
Interventions: Procedure: Transvaginal ultrasound; Procedure: Vaginal secretion sampling
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Completed - verified March 2012 - Condition: Lung Cancer
Interventions: Drug: PF-00299804; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Bipolar Disorder
Intervention: Behavioral: Mindfulness-Based Cognitive Therapy
Sponsors: Douglas Mental Health University Institute; Douglas Mental Health University Institute
Active, not recruiting - verified January 2012 - Condition: Obesity
Intervention: Behavioral: 2-day preceptorship on obesity management
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Colorectal Cancer
Intervention: Other: Needle core biopsies of liver metastasis
Sponsors: Jewish General Hospital; Jewish General Hospital; Quebec Clinical Research Organization in Cancer; Fonds de la Recherche en Santé du Québec
Recruiting - verified September 2011 - Condition: Fibromyalgia
Interventions: Drug: quetiapine; Drug: placebo
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Université de Montréal
Completed - verified October 2011 - Conditions: Colon Cancer; Inflammatory Bowel Diseases; Diverticulitis
Interventions: Drug: Lidocaine; Procedure: Epidural Block; Drug: PCA Morphine
Sponsors: McGill University Health Center; McGill University Health Center
Completed - verified November 2011 - Conditions: Asthma; Rhinitis
Intervention: Drug: Mometasone furoate and desloratadine
Sponsors: Laval University; Laval University
Recruiting - verified February 2012 - Condition: Neuropathic Pain
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Completed - verified April 2012 - Conditions: Male Infertility; Varicoceles
Intervention: Procedure: Varicocelectomy
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; McGill University; Dalhousie University; McMaster University
Not yet recruiting - verified August 2011 - Condition: Asthma
Interventions: Behavioral: Aerobic exercise; Behavioral: Usual care
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; McGill University Health Center
Recruiting - verified October 2011 - Condition: Coronary Artery Disease
Intervention: Behavioral: Multi-disciplinary disease management approach
Sponsors: Laval University; Laval University; Fonds de la Recherche en Santé du Québec
Completed - verified February 2012 - Condition: Preeclampsia
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Fondation des étoiles
Recruiting - verified March 2012 - Conditions: Obstetric Labor Complications; Prolonged Pregnancy
Intervention:
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke; Fonds de la Recherche en Santé du Québec
Recruiting - verified December 2011 - Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Luzerner Kantonsspital; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Recruiting - verified March 2012 - Condition: Anterior Wall Myocardial Infarction
Interventions: Biological: Plasma-Lyte A and 25% Autologous Plasma; Biological: Autologous EPCs; Biological: Autologous EPCs Transfected with human eNOS
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified May 2012 - Condition: Spinal Cord Injuries
Intervention:
Sponsors: McGill University; McGill University; Rick Hansen Foundation; Shriners Hospitals for Children; Fondation pour la Recherche sur la Moelle Épinière (Spinal Cord Research Foundation)
Withdrawn - verified July 2011 - Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid; Drug: Rifampin
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Rosuvastatin-omeprazole; Drug: Rosuvastatin-pantoprazole; Drug: Rosuvastatin-esomeprazole; Drug: Rosuvastatin-ranitidine; Drug: Atorvastatin-omeprazole; Drug: Atorvastatin-pantoprazole; Drug: Atorvastatin-esomeprazole; Drug: Atorvastatin-ranitidine
Sponsors: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Completed - verified February 2012 - Conditions: Nausea and Vomiting; Pain; Sleep Disorders; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride; Other: questionnaire administration; Procedure: management of therapy complications
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Terminated - verified July 2011 - Condition: Mobility Limitations
Intervention: Device: Assistive technology updating and tune up intervention
Sponsors: Université de Montréal; Université de Montréal
Completed - verified November 2011 - Condition: Actinic Keratosis
Interventions: Drug: Methylaminolevulinate (Metvix, Metvixia); Device: Photodynamic Therapy (Aktilite)
Sponsors: Innovaderm Research Inc.; Innovaderm Research Inc.; Galderma Canada
Completed - verified September 2011 - Conditions: Vitamin C Deficiency; Vitamin D Deficiency
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Vitamin C
Sponsors: Jewish General Hospital; Jewish General Hospital
Completed - verified June 2011 - Conditions: Gestational Diabetes Mellitus; Type 2 Diabetes
Intervention: Procedure: Oral glucose tolerance test
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified November 2011 - Conditions: Pregnancy; Thrombophilia; Pregnancy Complications
Interventions: Drug: dalteparin sodium 5,000 IU prefilled syringes (antenatal); Drug: dalteparin sodium (after delivery - Control group)
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast CancerConditions: Breast Cancer; Invasive Breast Cancer
Intervention: Procedure: Sentinel Lymph Node Biopsy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Fondation du cancer du sein du Québec
Recruiting - verified June 2011 - Condition: Chronic Pain
Intervention: Behavioral: Relaxation and information session
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified July 2011 - Condition: Torticollis
Intervention: Other: Booklet
Sponsors: McGill University Health Center; McGill University Health Center
Terminated - verified July 2011 - Condition: Coronary Artery Bypass Graft
Interventions: Procedure: Apnea; Procedure: High frequency ventilation
Sponsors: Montreal Heart Institute; Montreal Heart Institute
Recruiting - verified July 2011 - Condition: Cholestasis
Interventions: Drug: Ursodiol; Drug: placebo
Sponsors: St. Justine's Hospital; St. Justine's Hospital
Recruiting - verified July 2011 - Condition: Healthy
Interventions: Dietary Supplement: Vitamin D, cholecalciferol; Dietary Supplement: Vitamin D, cholecalciferol
Sponsors: McGill University; McGill University
Completed - verified March 2012 - Condition: Liver Tumors
Intervention:
Sponsors: Foothills Medical Centre; Foothills Medical Centre; Vancouver General Hospital; London Health Sciences Centre; Centre Hospitalier de l'Université de Montréal
Recruiting - verified March 2012 - Condition: Chronic Kidney Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified November 2011 - Condition: Head and Neck Cancer
Interventions: Biological: panitumumab; Drug: cisplatin; Radiation: 3-dimensional conformal radiation therapy; Radiation: accelerated radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified November 2011 - Condition: Fall Related Injury Risk
Intervention: Device: CDS for psychotropic drug management
Sponsors: McGill University; McGill University; Canadian Patient Safety Institute
Recruiting - verified March 2012 - Condition: Cystic Fibrosis
Interventions: Other: Positive Expiratory Pressure (PEP); Other: High Frequency Chest Wall Oscillation (HFCWO) using InCourage Vest System
Sponsors: University of British Columbia; University of British Columbia; Canadian Cystic Fibrosis Foundation
Active, not recruiting - verified April 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Medstar Research Institute; Medstar Research Institute
Active, not recruiting - verified April 2012 - Conditions: Conscious Sedation; Anxiety
Interventions: Behavioral: Parental presence; Behavioral: Control
Sponsors: St. Justine's Hospital; St. Justine's Hospital; Association des Médecins d'Urgence du Quebec
Recruiting - verified August 2011 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cediranib maleate; Drug: paclitaxel; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified March 2012 - Condition: Irritable Bowel Syndrome
Interventions: Other: Probaclac; Other: Placebo
Sponsors: St. Justine's Hospital; St. Justine's Hospital; Nicar Inc.
Recruiting - verified October 2011 - Condition: Venous Thromboembolism
Intervention:
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Heart and Stroke Foundation of Ontario
Recruiting - verified June 2011 - Condition: Healthy
Intervention: Dietary Supplement: Fructose powder
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Sir Mortimer B. Davis - Jewish General Hospital
Completed - verified February 2009 - Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus; Genetic: gene expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Gastroenteritis
Interventions: Drug: Lacidophil (experimental high dose); Drug: Lacidophil (experimental standard dose); Drug: Placebo
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children
Recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; Southwestern Oncology Group (SWOG); Cancer and Leukemia Group B
Active, not recruiting - verified May 2012 - Conditions: Infertility; Clinical Pregnancy Rate
Intervention: Procedure: Endometrial sampling
Sponsors: McGill University Health Center; McGill University Health Center
Terminated - verified October 2009 - Condition: Ovarian Carcinoma
Intervention: Dietary Supplement: Double-Brewed Green Tea
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; The Cancer Research Society
Active, not recruiting - verified February 2012 - Condition: Influenza
Intervention: Biological: Inactivated Influenza Vaccine Trivalent Types A and B (Split Virion)
Sponsors: British Columbia Centre for Disease Control; British Columbia Centre for Disease Control
Completed - verified July 2011 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Critical Illness
Interventions: Procedure: Protocolized Sedation; Procedure: Protocolized sedation, with daily interruption
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute
Active, not recruiting - verified September 2011 - Condition: Insomnia
Interventions: Behavioral: professionally administered cognitive-behavioral therapy; Behavioral: self-administered form of cognitive-behavioral therapy; Behavioral: placebo
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; Canadian Breast Cancer Research Alliance
Recruiting - verified August 2010 - Conditions: Clinically Isolated Syndromes; Early Single Relapse of Multiple Sclerosis
Interventions: Drug: Apo-Minocycline; Drug: Placebo Comparator
Sponsors: University of Calgary; Dr. Luanne Metz; Multiple Sclerosis Society of Canada
Recruiting - verified March 2012 - Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Drug: brivanib alaninate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Respiratory Insufficiency of Prematurity
Intervention: Other: Titration of oxygen therapy
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Carpal Tunnel Syndrome
Intervention: Procedure: Active Comparator, ischemic compressions
Sponsors: Guy Hains Chiropractor; Guy Hains Chiropractor
Completed - verified June 2011 - Condition: Compression Neuropathy, Carpal Tunnel
Intervention: Procedure: Ischemic Compression (thumb Pressure)
Sponsors: Guy Hains Chiropractor; Guy Hains Chiropractor
Completed - verified June 2010 - Conditions: Intracranial Aneurysm; Subarachnoid Hemorrhage
Intervention: Procedure: endovascular coil embolization
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified January 2012 - Conditions: Hepatic Insufficiency; Liver Failure
Interventions: Other: Preoperative glucose infusion; Other: Preoperative normal saline infusion
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified February 2012 - Condition: Healthy
Intervention: Dietary Supplement: Clarinol CLA
Sponsors: McGill University; McGill University
Completed - verified March 2012 - Condition: Hip Fractures
Intervention: Device: Dynamic Hip Screw (DHS); Trochanteric Fixation Nail (TFN)
Sponsors: McGill University Health Center; McGill University Health Center; Orthopaedic Trauma Association
Active, not recruiting - verified August 2011 - Conditions: Bipolar Type II Disorder; Depression, Bipolar
Interventions: Device: Northern Light Technology (SADelite lamp) bright light-therapy; Device: Northern Light Technology (SADelite lamp) Dim light-therapy
Sponsors: Douglas Mental Health University Institute; Douglas Mental Health University Institute; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified January 2012 - Conditions: Bariatric Surgery; Obesity; Respiratory Diseases
Intervention:
Sponsors: Laval University; Laval University
Completed - verified February 2012 - Conditions: Obesity; Asthma
Intervention:
Sponsors: Laval University; Laval University
Completed - verified February 2012 - Conditions: Asthma; Obesity
Intervention:
Sponsors: Laval University; Laval University
Completed - verified February 2012 - Condition: Distal Radius Fractures
Interventions: Procedure: Open Reduction and Internal Fixation; Procedure: Non-Spanning External Fixation; Procedure: Closed Reduction with Percutaneous Fixation
Sponsors: McGill University Health Center; McGill University Health Center; Orthopaedic Trauma Association
Recruiting - verified August 2011 - Conditions: Leukemia; Myelodysplastic Syndromes
Intervention: Drug: cytarabine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Melanoma (Skin)
Interventions: Biological: recombinant human interleukin-21; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Procedure: quality-of-life assessment; Radiation: Radiation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified March 2012 - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Ritalin; Drug: Placebo
Sponsors: McGill University; McGill University
Recruiting - verified February 2012 - Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Doxorubicin; Drug: Cytarabine; Drug: Methotrexate; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Methylprednisone; Drug: Hydrocortisone Sodium Succinate; Drug: Dexamethasone; Drug: 6-MP; Drug: PEG-Asparaginase; Drug: Imatinib; Drug: Etoposide; Procedure: Radiation Therapy; Drug: E. coli Asparaginase
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute; Massachusetts General Hospital; Children's Hospital Boston
Recruiting - verified August 2011 - Condition: Breast Cancer
Interventions: Other: Interview; Procedure: Blood and Tissue Collection
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified February 2012 - Condition: the Efficacy and Safety of Off-pump CABG
Interventions: Procedure: Coronary Artery Bypass Graft with the use of CPB; Procedure: Coronary Artery Bypass Graft without the use of CPB
Sponsors: Population Health Research Institute; Population Health Research Institute; McMaster University; University of Oxford; Instituto Dante Pazzanese de Cardiologia; ECLA Clinical Research Organization,; Fu Wai Hospital, Beijing, China; Facultad de Medicina, Universidad de La Frontera, Temuco, Chile; Fundación Cardiovascular de Colombia; Charles University, Czech Republic; Hopital Jean Minjoz; Centre for Chronic Disease Control, India; S. C. di Cardiochirurgia, Ospedale Santa Croce a Carle, Cuneo, Italy; Medical University of Gdansk; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ankara University; Hotel Dieu Hospital; Centre hospitalier de l'Université de Montréal (CHUM); SAL Hospital, Ahmedabad, India
Recruiting - verified July 2011 - Conditions: Parkinson's Disease; Excessive Daytime Somnolence
Interventions: Drug: Caffeine 100-200 mg BID; Drug: placebo
Sponsors: McGill University Health Center; McGill University Health Center; Canadian Institutes of Health Research (CIHR); University of Toronto
Completed - verified July 2011 - Condition: Cystic Fibrosis
Interventions: Drug: azithromycin 250 mg tablets; Drug: placebo tablets
Sponsors: CF Therapeutics Development Network Coordinating Center; CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Completed - verified February 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bortezomib; Drug: cyclophosphamide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Supraventricular Tachycardia in Infants
Intervention: Drug: digoxin and propranolol
Sponsors: University of British Columbia; University of British Columbia; The Hospital for Sick Children; University of Utah
Completed - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus; Drug: temozolomide; Genetic: microarray analysis; Other: immunohistochemistry staining method
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Vitamin D Deficiency
Interventions: Drug: Vitamin D; Drug: Vitamin D; Drug: Vitamin D
Sponsors: McGill University; McGill University
Completed - verified March 2012 - Condition: Lymphoma
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified June 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: AEG35156; Drug: docetaxel; Genetic: protein expression analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: flow cytometry; Other: immunoenzyme technique; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: AEG35156; Drug: docetaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Bladder Cancer
Interventions: Biological: BCG vaccine; Drug: gefitinib; Procedure: quality-of-life assessment
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Lung Cancer
Intervention: Radiation: 3-dimensional conformal radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Conditions: Leukemia; Lymphoma
Interventions: Biological: alemtuzumab; Biological: anti-thymocyte globulin; Biological: filgrastim; Biological: rituximab; Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: methotrexate; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); German CLL Study Group
Active, not recruiting - verified April 2007 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Condition: Cerebral Palsy
Interventions: Procedure: Upper Extremity Tendon transfer; Procedure: Botulinum Toxin injections in Upper Extremity; Procedure: Regularly ongoing therapy
Sponsors: Shriners Hospitals for Children; Shriners Hospitals for Children
Recruiting - verified January 2012 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Hypertension
Interventions: Drug: Candesartan Thiazide; Drug: Atenolol Thiazide; Drug: Thiazide Candesartan
Sponsors: Institut de Recherches Cliniques de Montreal; Institut de Recherches Cliniques de Montreal; Ottawa Hospital Research Institute
Completed - verified September 2005 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Condition: Asthma
Intervention: Device: computer-based decision support for asthma management
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Angina Pectoris
Intervention: Drug: Ivabradine
Sponsors: Servier; Institut De Recherche International Servier
Completed - verified June 2011 - Condition: Latent Tuberculosis Infection
Intervention: Drug: Isoniazide (drug), Rifampin (drug)
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Toxemia
Intervention: Behavioral: preeclampsia
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Procedure: Radial Artery and Saphenous Vein Grafts Randomized to either right coronary or left circumflex coronary artery territories
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR)
Completed - verified November 2011 - Condition: Opiate Addiction
Interventions: Drug: Methadone; Drug: Diamorphine hydrochloride
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified October 2011 - Condition: Deep Vein Thrombosis
Interventions: Procedure: D-dimer testing; Procedure: D-dimer testing
Sponsors: McMaster University; McMaster University; Heart and Stroke Foundation of Ontario
Completed - verified October 2011 - Condition: Deep Vein Thrombosis
Intervention: Procedure: various diagnostic measures for DVT (e.g., CUS)
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Completed - verified October 2007 - Conditions: Coagulation; Bleeding; Thrombosis
Intervention: Drug: Phytonadione (Vitamin K1)
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton; McMaster University
Completed - verified July 2011 - Condition: Syncope, Vasovagal, Neurally-Mediated
Intervention: Drug: fludrocortisone acetate
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Completed - verified April 2012 - Condition: Retinoblastoma
Interventions: Biological: filgrastim; Drug: carboplatin; Drug: cyclosporine; Drug: etoposide; Drug: vincristine sulfate; Procedure: cryosurgery; Procedure: laser therapy; Procedure: neoadjuvant therapy
Sponsors: National Cancer Institute (NCI); The Hospital for Sick Children
Recruiting - verified April 2009 - Condition: Breast Cancer
Intervention: Drug: exemestane
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Grupo Espanol de Investigacion del Cancer de Mama; UNICANCER
Active, not recruiting - verified August 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: pegfilgrastim; Drug: docetaxel; Drug: epirubicin hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: CHOP regimen
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Drug: topotecan hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: epoetin alfa; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: paclitaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group
Active, not recruiting - verified May 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone; Drug: thalidomide
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Interventions: Drug: carboplatin; Drug: gemcitabine hydrochloride
Sponsors: National Cancer Institute (NCI); AGO Study Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified June 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Sarcoma
Intervention: Drug: alvocidib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone; Drug: melphalan; Drug: prednisone
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: octreotide acetate; Drug: tamoxifen citrate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified March 2012 - Condition: Lung Cancer
Interventions: Drug: marimastat; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: vinblastine; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group
Completed - verified January 2012 - Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011


